Satellos Bioscience INC. (MSLE) — SEC Filings
Latest SEC filings for Satellos Bioscience INC.. Recent 6-K filing on Apr 9, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
View Satellos Bioscience INC. on SEC EDGAR
Overview
Satellos Bioscience INC. (MSLE) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Apr 9, 2026: Satellos Bioscience Inc. filed a Form 6-K on April 9, 2026, reporting information as a foreign issuer. The filing includes a press release as an exhibit, but no specific financial figures or operational updates are detailed in the provided metadata.
Sentiment Summary
Across 4 filings, the sentiment breakdown is: 4 neutral. The dominant filing sentiment for Satellos Bioscience INC. is neutral.
Filing Type Overview
Satellos Bioscience INC. (MSLE) has filed 2 6-K, 1 S-8, 1 40-F with the SEC between Mar 2026 to Apr 2026.
Recent Filings (4)
-
Satellos Bioscience Files 6-K Report
— 6-K · Apr 9, 2026 Risk: low
Satellos Bioscience Inc. filed a Form 6-K on April 9, 2026, reporting information as a foreign issuer. The filing includes a press release as an exhibit, but no - S-8 Filing — S-8 · Mar 27, 2026
-
Satellos Bioscience Files 40-F for FY2025
— 40-F · Mar 27, 2026 Risk: low
Satellos Bioscience Inc. filed its 40-F form on March 27, 2026, reporting on its fiscal year ending December 31, 2025. The filing includes various exhibits such -
Satellos Bioscience Files 6-K Report
— 6-K · Mar 27, 2026 Risk: low
Satellos Bioscience Inc. filed a Form 6-K on March 27, 2026. This report includes a press release as an exhibit, but the specific details of the press release,
Risk Profile
Risk Assessment: Of MSLE's 3 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 3 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Top Tags
disclosure (1) · foreign-issuer (1) · regulatory (1) · annual-report (1) · foreign-private-issuer (1) · sec-filing (1) · 6-k (1) · regulatory-update (1)
Frequently Asked Questions
What are the latest SEC filings for Satellos Bioscience INC. (MSLE)?
Satellos Bioscience INC. has 4 recent SEC filings from Mar 2026 to Apr 2026, including 2 6-K, 1 S-8, 1 40-F. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of MSLE filings?
Across 4 filings, the sentiment breakdown is: 4 neutral. The dominant sentiment is neutral.
Where can I find Satellos Bioscience INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Satellos Bioscience INC. (MSLE) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Satellos Bioscience INC.?
Financial highlights for Satellos Bioscience INC. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for MSLE?
Investment thesis data for MSLE will be available once enriched filings are processed.
Who are the key executives at Satellos Bioscience INC.?
Executive information for Satellos Bioscience INC. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Satellos Bioscience INC. stock?
Of MSLE's 3 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 3 low-risk.
What are recent predictions and forward guidance from Satellos Bioscience INC.?
Forward guidance and predictions for Satellos Bioscience INC. are extracted from SEC filings as they are enriched.